Stocks Explorer
Stocks
Sectors
Search
Anavex Life Sciences Corp.(0HFR) News
Profile
Chart
News
Analysis
0HFR price today
by TradingView
Date
Title
Jan 16
Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
‹ Prev
Page
of 1
Next ›